Details
Category: Volume 07 Issue 05 May 2019
Hits: 1062

Title: Study of Development of Non-Alcoholic Fatty Liver Disease (NAFLD) among Type-2 Diabetes Mellitus

Authors: Dr Shivani Bansal, Dr Nilay Singh Rajput

 DOI: https://dx.doi.org/10.18535/jmscr/v7i5.58

Abstract

Introduction

Type 2 diabetes mellitus is a metabolic disorder of fuel homoeostasis characterized by hyperglycemia and altered lipid metabolism caused by islet b-cells being unable to secrete adequate insulin in response to varying degrees of over nutrition, inactivity, consequential overweight and insulin resistance.

Diabetes mellitus and lesser forms of glucose intolerance, particularly impaired glucose tolerance, can now be found in almost every population in the world and epidemiological evidence suggests that, without effective prevention and control programs, diabetes will likely to continue to increase globally.1

References

  1. World Health Organization. Prevention of diabetes mellitus. Technical Report Series no. 844.Geneva: World Health Organization, 1994.
  2. King H, Rewers M. Diabetes in adults is now a Third World problem. The WHO Ad Hoc Diabetes Reporting Group. Bull World Health Organ 1991;69:643-8.
  3. Bjork S, Kapur A, King H, Nair J, Ramachandran A.2.Global policy: aspects of diabetes in India. Health Policy 2003;66:61-72
  4. Sicree R,Shaw J, Zimmet P. Diabetes and impaired glucose tolerance. In: Gan D, editor. Diabetes atlas. International Diabetes Federation. Belgium: International Diabetes Federation; 2009. (4th ed)p.1-105.
  5. Mather HM, Verma NP, Mehta SP, Madhu SV, Keen H. The Prevalence of known diabetes in Indians in New Delhi and London. J Med Assos Thai 1987;70:54-8.
  6. Deepa R, Sandeep S, Mohan V. Abdominal obesity, visceral fat 5.and Type 2 diabetes- "Asian Indian Phenotype”. In: Mohan V, Gundu HR Rao, editors. Type 2 diabetes in South Asians: Epidemiology, risk factors and prevention. New Delhi: Jaypee Brothers Medical Publishers; 2006.p.138-52
  7. Joshi R. Metabolic syndrome - Emerging clusters of the Indian Phenotype. J Assoc Physicians India2003;51:445-6.
  8. Yan E, Durazo F, Tong M, Hong K. Nonalcoholic fatty liver disease: pathogenesis, identification, progression, and management. Nutr Rev 2007;65 (8):376-84.
  9. Kallwitz ER, Kumar M, Aggarwal R, Berger R, Layden Almer J, Gupta N, Cotler SJ, Ethnicity and nonalcoholic fatty liver disease in an obesity clinic: the impact of triglycerides, Dig Dis Sci 2008;53:1358-63.
  10. Erickson SK. Nonalcoholic fatty liver disease, J Lipid Res 2009:50(Suppl.): S412-6. Epub; 2008Dec 12.
  11. Radu C, Grigorescu M, Crisan D, Lupsor M, Constantin D, Dina L Prevalence and associated risk factors of non-alcoholic fatty liver disease in hospitalized patients. J Gastrointestin Liver Dis. 2008; 17(3):255-60.
  12. Chen CH, Huang MH, Yang JC,Nien CK, Yang CC, Yeh YH, Yueh SK, Prevalence and risk factors of nonalcoholic fatty liver disease in an adult population in Taiwan: metabolic significance of nonalcoholic fatty liver disease in non obese adults, J Clin Gastroenterol 2006;40(8):745-52.
  13. Cheung O, Sanyal AJ. Recent advances in nonalcoholic fatty liver disease, Curr Opin Gastroenterol 2009; 25(3):230-7.
  14. Lazo M, Clark JM. The epidemiology of nonalcoholic fatty liver disease:a global perspective. Semin Liver Dis 2008;28(4):339-50,
  15. Shah P, Basu A, Rizza R. Fat-induced liver insulin resistance. Curr Diabetes Rep. 2003;3:214-18.
  16. Nolan CJ. Failure of islet β-cell compensation for insulin resistanct causes type 2 diabetes: what causes NAFLD and NASH? J Gastroenterol1 Hepatol. 2010;25:1591-97.
  17. Lewis JR, Mohanty SR. Nonalcoholic fatty liver disease: a review and update. Digestive Diseases and Sciences.2010; 55(3):560-78.
  18. Angulo P. Medical progress: nonalcoholic fatty liver disease. The New England Journal of Medicine. 2002; 346(16):Z221-31.
  19. Smith BW and Adams LA. Nonalcoholic fatty liver disease and diabetes mellitus: pathogenesis and treatment. Nature Reviews Endocrinology. 2011;7(8): 456-65.
  20. Angulo P, Keach JC, Batts KP, Lindor KD. Independent predictors of liver fibrosis in patients witj nonalcoholic steatohepatitis. Hepatology. 1999; 30(6): 1356-62.
  21. R Haring, H. Wallaschofski, M. Nauck, S.E. Baumeister, H. V..olzke, “Ultrasono-graphic hepatic steatosis increases prediction of mortality risk from elevated serum gamma-glutamyltranspeptidase levels,” Hepatology. 2009; vol. 50; no. 5:pp. 1403-11.
  22. Ruhl CE, Everhart JE. Elevated serum alanine aminotransferase and gamma-glutamyltransferase and mortality in the United States population. Gastroente-rology. 2009;136(2): 477-85.
  23. Bedogni G, Bellentani S, Miglioli L. The fatty liver index:a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterology 2006;33.
  24. Dixon J. Bhathal P, O'Brien P. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 2001;121(1):91-100
  25. Ratziu V, Massard J, Charlotte F. Diagnostic value of biochemical markers (Fibro Test-Fibro SURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease. BMC Gastroenterology 2006;6.
  26. Saadeh S, Younossi Z, Remer E. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002;123(3):745-750.
  27. A. Marrero, R.J. Fontana, G.L. Su, Conjeevaram H, Emick D, Lok S.NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States. Hepatology 2002;36(6):1349-1352.
  28. Osawa H, Y. Mori Y. Sonographic diagnosis of fatty liver using a histogram technique that compares liver and renal cortical echo amplitudes. Journal of Clinical Ultrasound 1996;24(1):25-29.
  29. Sanyal A.AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 2002;123(5):1705-1725.
  30. Browning J, Szczepaniak L, Dobbins R. Prevalence of hepatic steatosis in an urban population in the united states: impact of ethnicity. Hepatology 2004; 40(6): 1387-1395.
  31. Fan J, Zhu J, Li XJ. Prevalence of and risk factors for fatty liver in a general population of Shanghai, China. Journal of Hepatology 2005;(3):508-514.
  32. Jimba S, Nakagami T, Takahashi M. Prevalence of non-alcoholic fatty liver disease and Itsassociation with impaired glucose metabolism in Japanese adults. Diabetic Medicine 2005;22(9):1141-1145.
  33. Gupte P, Amarapurkar D, Agal S. Non-alcoholic steatohepatitis in type 2 diabetes mellitus. Journal of Gastroenterology and Hepatology 2004;19(8):854-858.
  34. Vishwanathan V, Mahesh K. Association of non-alcoholic fatty liver disease with diabetic microvascular and macrovascular complications in south Indian subjects. International journal of diabetes in developing countries 2010;4.
  35. Vera S, Ferreira G, Pernambuco B. Frequency and risk factors associated with non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus. Arq Bras Endocrinol Metab.2010;54(4).
  36. Chung Fu C, Chen M. The Risk Factors for Ultrasound-diagnosed Non-alcoholic Fatty Liver Disease among Adolescents. Ann Acad Med Singapore 2009;(38):15-21.

Corresponding Author

Dr Nilay Singh Rajput

Post-Graduate 2nd Year, Santosh Medical College & Hospital